This Sunday September 16 the Castlegar & District Recreation Centre will host the Terry Fox Run! EVERYONE is welcome! Registration begins at 8:30 am and the 1, 5 or 10 km run begins at 9 a.m. at the Castlegar Community Complex! You can walk or ride or run and dogs are welcome on a leash! There is No minimum donation. A Great Family Event!
This year Castlegar is issuing a “bank challenge”. Each bank will be encouraged to have their staff participate on Sept. 16th – Terry Fox Day. The bank with the highest ratio of staff taking part in Terry’s walk will be rewarded by Tim Horton’s coffee and pastries as well as lunch provided by Subway. These coffee and lunch treats will be delivered to the winning bank.
Zellstoff Celgar is showing their support for the Terry Fox Run with an in house staff challenge.
A quote from Terry – ‘Even if I don’t finish, we need others to continue. It’s got to keep going without me”!
Will you join the cause on Sunday, September 16 at the Castlegar Complex? For further information go online at www.terryfox.org or contact Audrey at 250 365-3386 email email@example.com.
For millions of people worldwide Terry Fox is the face of cancer research. His Marathon of Hope inspired a country and The Terry Fox Run, now in its fourth decade, continues to motivate people here in Canada and around the world. To date, over $600 million has been raised in support of Terry’s cause.
Terry’s vision and courage have helped to change and reshape Canada in many ways. Importantly, it transformed cancer research here – establishing a new attitude and threshold regarding what kind of investment was necessary to support cancer research. The Terry Fox Foundation (“TFF”) continues to be a leading national investor in cancer research.
TFF remains true to Terry’s wishes today by directing all funds rose in his name to cancer research. For more than 31 years, funds have been provided to support cure-oriented, biomedical cancer research around the globe. In 2007, the Foundation created The Terry Fox Research Institute (“TFRI”), with a mandate to conduct translational research to significantly improve outcomes for patients.
In the previous fiscal year (ending March 31, 2012), TFF directed $27.5 million to its cancer research programs.